FW: URGENT MEDICINE RECALL: DBL-METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL bags

[Michael Wishart]

[Posted on behalf of Donna Cameron Moderator]

Dear Infexion Connexion subscribers,

Further to the Product Defect Alert previously distributed (6 June 2018), this has now become an urgent product recall for DBL METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag. See attached PDF for further details.

Regards,
Donna

Donna Cameron
Infection Control Consultant
T +61 (0) 3 8344 3574 (Monday, Wednesday & Friday); +61 (0) 3 9096 5233 (Tuesday & Thursday)
donna.cameron@unimelb.edu.au
Microbiological Diagnostic Unit Public Health Laboratory
The Peter Doherty Institute for Infection and Immunity
792 Elizabeth Street | Melbourne | Victoria | Australia | 3000
doherty.edu.au
[cid:image001.gif@01D40DFE.9A30CA10][cid:image002.gif@01D40DFE.9A30CA10]
[cid:image003.gif@01D40DFE.9A30CA10]

From:

“Australian Society for Antimicrobials” <info@asainc.net.au>

To:

“ASA” <info@asainc.net.au>

Date:

26/06/2018 08:10 PM

Subject:

URGENT MEDICINE RECALL: DBL??? METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL bags

________________________________

PO Box 8266 Angelo Street
South Perth 6151 Western Australia
ABN: 31 081 739 370

Email: info@asainc.net.au
Twitter: @AusAntibiotics

Member Update 26 Jun 2018
Pfizer Australia wish to advise of an urgent medicine recall for DBL METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag. See attached letter. This is an escalation from the Urgent Product Defect Correction letter issued early June 2018.

Please contact Wayne Lee if you wish to discuss this matter further:

Wayne Lee
Associate Medical Director
Pfizer Essential Health
Tel: +61 3 8744 5103
Mob: +61 401 100 383

Australian Society for Antimicrobials :: https://www.asainc.net.au

______________________________________________________________________
This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.

______________________________________________________________________
This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.

MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.

[Author]

Posts